MAGE-A4 Interacts with the Liver Oncoprotein Gankyrin and Suppresses Its Tumorigenic Activity
Open Access
- 1 March 2003
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (12) , 10668-10674
- https://doi.org/10.1074/jbc.m206104200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A novel protein overexpressed in hepatoma accelerates export of NF-κB from the nucleus and inhibits p53-dependent apoptosisCancer Cell, 2002
- Generation of CTL Recognizing an HLA-A*0201-Restricted Epitope Shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 Tumor Antigens: Implication in a Broad-Spectrum Tumor ImmunotherapyThe Journal of Immunology, 2002
- Novel Insights into the INK4-CDK4/6-Rb Pathway: Counter Action of Gankyrin against INK4 Proteins Regulates the CDK4-Mediated Phosphorylation of RbBiochemistry, 2002
- Gankyrin Is an Ankyrin-repeat Oncoprotein That Interacts with CDK4 Kinase and the S6 ATPase of the 26 S ProteasomeJournal of Biological Chemistry, 2002
- The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic diseaseJournal of Neuroscience Research, 2002
- Overexpression ofp28/gankyrinin human hepatocellular carcinoma and its clinical significanceWorld Journal of Gastroenterology, 2002
- Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: Induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16INK4A exon 1 in hepatocellular carcinomaMolecular Carcinogenesis, 2001
- Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomasNature Medicine, 2000
- A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytesEuropean Journal of Immunology, 1999
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991